Survival and health in liveborn infants with transposition of great arteries--a population-based study

Congenit Heart Dis. 2007 May-Jun;2(3):165-9. doi: 10.1111/j.1747-0803.2007.00093.x.

Abstract

Objective: To describe treatment, survival, and morbidity for liveborn infants with isolated transposition of great arteries (TGA).

Design: Population-based data from 7 European registries of congenital malformations (EUROCAT).

Results: Ninety-seven infants were diagnosed with isolated TGA and livebirth prevalence was 2.0 per 10,000 livebirths. The majority of infants were treated with prostaglandins (83%) and 57% had a catheter atrial septostomia performed. Arterial switch surgery was performed in 78 infants, other or unknown type of surgery was performed in 3 cases, and for 6 infants there was no information on surgery. At 1 year of age 69 infants were alive (71%) and 24 (25%) were dead (4 unknown). There were 10 deaths before surgery and 58% of all deaths took place during the first week. There was no statistically significant regional difference in mortality. Eight infants diagnosed prenatally all survived to 1 year and only 71% of infants diagnosed after birth survived (P = 0.08). Data on morbidity at 1 year of age was available for 57 infants. Fifty-one infants were reported with normal health and development.

Conclusions: In this population-based study survival for liveborn infants with TGA is lower than in studies published from tertiary centers. Outcome for survivors at 1 year of age seems favorable.

MeSH terms

  • Cardiac Surgical Procedures
  • Follow-Up Studies
  • Humans
  • Infant Welfare*
  • Infant, Newborn
  • Live Birth*
  • Prenatal Diagnosis
  • Prevalence
  • Prostaglandins / therapeutic use
  • Registries
  • Survival Analysis
  • Transposition of Great Vessels / epidemiology
  • Transposition of Great Vessels / mortality*
  • Transposition of Great Vessels / physiopathology*
  • Transposition of Great Vessels / therapy

Substances

  • Prostaglandins